Investment
Features
FeesSafety
Academy
More
Pluang+

Compare iShares MSCI India ETF (INDA) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

iShares MSCI India ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

iShares MSCI India ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? iShares MSCI India ETF trades at $47.6 (market cap $5.81B), while Vir Biotechnology Inc. Common Stock trades at $10.38 (market cap $1.76B). The key difference: iShares MSCI India ETF is far larger — about 3.3× Vir Biotechnology Inc. Common Stock's market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI India ETF for 60 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

INDAVIR
Market Cap
$5.81B$1.76B
Volume
11,821,0582,764,948
Sector
Broad Market / FactorHealth
52-Week High
$55.29$11.78
52-Week Low
$45.42$5.12
Typical Hold Time
60 Days0 Days
Enterprise Value
—$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

iShares MSCI India ETF

INDA trades at $47.24, up 1.99% today, but technical indicators show a bearish trend with moving averages signaling sell pressure. The ETF faces headwinds from India's economic challenges including coal power shortages, below-average monsoon rains, and pharmaceutical sector export issues. Recent news highlights India's energy security concerns and IT sector weakness, creating a cautious market environment despite the country's economic growth narrative.

The outlook remains cautious with technical weakness outweighing short-term gains. Investment opportunity exists for long-term exposure to India's growth story, but risks include energy sector instability, weather-dependent agricultural output, and global trade tensions affecting key export industries.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDA
100% Buy0% Sell
Avg holding period · 60 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

About iShares MSCI India ETF

INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.

Read more on INDA →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →